Washington, April 8 -- Representative Mike Quigley issued the following press release:
This week, Representatives Mike Quigley (IL-05) and Ken Calvert (CA-41) introduced the Accelerating Access to Critical Therapies for ALS Reauthorization Act (ACT for ALS Reauthorization Act) of 2026. The ACT for ALS Reauthorization Act will help people living with ALS continue to access promising treatments and further advance the scientific understanding of neurodegenerative diseases. Today, the ACT for ALS Reauthorization Act was noticed for a hearing at the Energy and Commerce Health Subcommittee on April 15, 2026.
"Every dollar put towards ACT for ALS programs has improved our understanding of ALS and allowed people living with ALS to access promisi...